Prairiewood Capital, LLC Fulgent Genetics, Inc. Transaction History

Prairiewood Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	BUY	$29.39 - $36.27 $37,648 - $46,461	1,281 Added 16.74%	8,933 $278,000
Q4 2022 Jan 20, 2023	SELL	$29.23 - $40.28 $3,390 - $4,672	-116 Reduced 1.49%	7,652 $0
Q3 2022 Oct 13, 2022	SELL	$37.92 - $63.74 $5,157 - $8,668	-136 Reduced 1.72%	7,768 $296,000
Q2 2022 Jul 13, 2022	BUY	$47.98 - $62.75 $11,563 - $15,122	241 Added 3.14%	7,904 $431,000
Q1 2022 Apr 20, 2022	BUY	$49.85 - $96.11 $90,427 - $174,343	1,814 Added 31.01%	7,663 $478,000
Q4 2021 Jan 20, 2022	SELL	$77.3 - $105.0 $12,136 - $16,485	-157 Reduced 2.61%	5,849 $588,000
Q3 2021 Oct 13, 2021	BUY	$74.87 - $110.87 $88,047 - $130,383	1,176 Added 24.35%	6,006 $540,000
Q2 2021 Jul 13, 2021	BUY	$66.8 - $100.45 $322,644 - $485,173	4,830 New	4,830 $445,000

200

16M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $513M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Prairiewood Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Prairiewood Capital, LLC with notifications on news.